A Year in Review: Experts Illuminate the Potential of ADCs Targeting HER2, HER3, and TROP-2 in NSCLC

Learn how experts are integrating the latest data on ADCs into clinical care of NSCLC with downloadable slides and an archived webcast of a live webinar, along with a focused commentary.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.